Research Article | 27 Dec 2022

A urinary proteomic study in hypercalciuric dogs with and without calcium oxalate urolithiasis

Sumonwan Chamsuwan1, Chollada Buranakarl1, Kris Angkanaporn1, Thasinas Dissayabutra2, Natthaya Chuaypen2, Trairak Pisitkun3, and Nuttiya Kalpongnukul3Show more
VETERINARY WORLD | pg no. 2937-2944 | Vol. 15, Issue 12 | DOI: 10.14202/vetworld.2022.2937-2944
Citations:

Cite this Article

  • APA
  • MLA
  • Chicago
  • Vancouver
  • Harvard

              
            

Abstract

Background and Aim: Hypercalciuria is an important predisposing factor commonly found in humans and dogs with calcium oxalate (CaOx) urolithiasis. Calcium oxalate crystals can induce an inflammatory reaction that subsequently produces several proteins that have an inhibitory or stimulatory effect on stone formation. This study aimed to evaluate the differences in urinary proteomic profiles between hypercalciuric CaOx stone dogs and hypercalciuric stone-free dogs (CaOx stone and control groups, respectively).

Materials and Methods: Seven dogs with hypercalciuric CaOx urolithiasis and breed-, sex-, and aged-matched controls with hypercalciuria were included in the study. Serum and urine samples were obtained from all dogs to analyze electrolytes. Urinary proteomic profiles were analyzed using liquid chromatography-mass spectrometry. Student's t-test was used to compare the differences between groups.

Results: Forty-nine urinary proteins were identified in the stone-free and CaOx stone groups, whereas 19 and 6 proteins were unique in the CaOx stone and stone-free groups, respectively. The urinary thrombomodulin level was significantly higher in the CaOx stone group (relative ratio = 1.8, p < 0.01) than in the stone-free group.

Conclusion: This study demonstrated that urinary proteomic profiles may be used as a candidate biomarker for urinary tract injury in CaOx urolithiasis in dogs. Keywords: calcium oxalate stone, dog, hypercalciuria, urinary biomarker.

Keywords: calcium oxalate stone, dog, hypercalciuria, urinary biomarker.